![Avisi technologies](/api/images/company-pic/0-1090535-company.png)
Свяжитесь с нами
О компании
Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma. Avisi's product, VisiPlate, is a next-generation aqueous shunt that aims to treat mid to late-stage glaucoma. It is 20x thinner than a human hair. VisiPlate leverages an ultrathin nanoplate and its insertion procedure reduces operating time and makes follow-up care easier. VisiPlate is made of alumina, an implant material that has been used in hip replacements. Avisi Technologies is headquartered in Philadelphia, Pennsylvania.
US
Неизвестно
Не проверенная компания
Прозрачность бизнеса
- Не проверена информация о компании
- Спрашивает отзывы у своих клиентов
- Не ответил на негативные отзывы